Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biosynthesis of the purines. XXI. 5-Phosphoribosylpyrophosphate amidotransferase.

Authors: Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal: Am J Hum Genet Date: 2010-04-09 Impact factor: 11.025

5. A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.

Authors: J B Wyngaarden; O Sperling; F Starmer
Journal: Trans Am Clin Climatol Assoc Date: 1973

6. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.

Authors: O Sperling; J B Wyngaarden; C F Starmer
Journal: J Clin Invest Date: 1973-10 Impact factor: 14.808

Biosynthesis of the purines. XXI. 5-Phosphoribosylpyrophosphate amidotransferase.

1. The biosynthesis and interconversion of purines and their derivatives.

2. Accelerated turnover of phosphoribosylpyrophosphate, a purine nucleotide precursor, in certain gouty subjects.

Review 3. A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.

Review 4. PRPS1 mutations: four distinct syndromes and potential treatment.

5. A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.

6. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.

7. Regulation and mechanism of phosphoribosylpyrophosphate synthetase: repression by end products.

Review 8. Hearing loss and PRPS1 mutations: Wide spectrum of phenotypes and potential therapy.

9. Purine biosynthesis in archaea: variations on a theme.

Review 10. Naturally occurring modified ribonucleosides.